Toca 511 & Toca FC: Evaluation of Durable Response Rate in the Post-Resection Setting and Association with Survival in Patients with Recurrent High Grade Glioma

被引:0
|
作者
Cloughesy, Timothy [1 ]
Landolfi, Joseph [2 ]
Vogelbaum, Michael [3 ]
Ostertag, Derek [4 ]
Elder, Bradley [5 ]
Carter, Bob [6 ]
Chen, Clark [7 ]
Kalkanis, Steven [8 ]
Kesari, Santosh [9 ]
Lai, Albert [1 ]
Lee, Ian [8 ]
Liau, Linda [1 ]
Nghiemphu, Phioanh [1 ]
Piccioni, David [10 ]
Accomando, William [4 ]
Diago, Oscar [4 ]
Hogan, Daniel [4 ]
Jolly, Douglas [4 ]
Wood, Katie [4 ]
Kheoh, Thian [4 ]
Gruber, Harry [4 ]
Das, Asha [4 ]
Walbert, Tobias [8 ]
机构
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] New Jersey Neurosci Inst, Edison, NJ USA
[3] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[4] Tocagen Inc, San Diego, CA USA
[5] Ohio State Univ, Columbus, OH 43210 USA
[6] MGH, Boston, MA USA
[7] Univ Minnesota, Minneapolis, MN USA
[8] Henry Ford Hosp, Detroit, MI 48202 USA
[9] John Wayne Canc Inst, Santa Monica, CA USA
[10] UCSD, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
S23.006
引用
收藏
页数:4
相关论文
共 42 条
  • [31] PHASE 1 TRIAL OF A RETROVIRAL REPLICATING VECTOR (TOCA 511) IN RECURRENT HIGH GRADE GLIOMA PATIENTS DEMONSTRATES THE IMPORTANCE OF REAL-TIME MRI-GUIDED DELIVERY FOR DOSE-RELATED EVALUATION OF SAFETY AND EFFICACY
    Aghi, Manish
    Vogelbaum, Michael A.
    Jolly, Douglas J.
    Robbins, Joan M.
    Ostertag, Derek
    Ibanez, Carlos E.
    Gruber, Harrry E.
    Kasahara, Noriyuki
    Bankiewicz, Krystof
    Cloughesy, Timothy F.
    Chang, Susan M.
    Butowski, Nicholas
    Kesari, Santosh
    Chen, Clark
    Mikkelsen, Tom
    Landolfi, Joseph
    Chiocca, E. Antonio
    Elder, J. Bradley
    Foltz, Greg
    Pertschuk, Dan
    NEURO-ONCOLOGY, 2013, 15 : 217 - 217
  • [32] SYSTEMATIC IDENTIFICATION OF TOCA 511 RETROVIRUS INTEGRATION SITES AND MUTATION PROFILES IN TUMOR AND BLOOD SAMPLES FROM PATIENTS UNDERGOING INVESTIGATIONAL TREATMENT FOR RECURRENT HIGH GRADE GLIOMA CORRELATES WITH FAVORABLE CLINICAL SAFETY PROFILE
    Hogan, Daniel
    Diago, Oscar
    Gammon, Dawn
    Haghighi, Ali
    Jolly, Douglas
    Ostertag, Derek
    NEURO-ONCOLOGY, 2016, 18 : 23 - 23
  • [33] RE-RESECTION FOR RECURRENT HIGH GRADE GLIOMA IN THE SETTING OF RE-IRRADIATION: SURVIVAL OUTCOMES UPDATE
    Palmer, Joshua
    Siglin, Joshua
    Yamoah, Kosj
    Dan, Tu
    Champ, Colin
    Kim, Lyndon
    Glass, Jon
    Werner-Wasik, Maria
    Farrell, Christopher
    Evans, James
    Andrews, David
    Shi, Wenyin
    NEURO-ONCOLOGY, 2014, 16
  • [34] Association between extent of resection on survival in adult brainstem high-grade glioma patients
    Doyle, Joshua
    Khalafallah, Adham M.
    Yang, Wuyang
    Sun, Yi
    Bettegowda, Chetan
    Mukherjee, Debraj
    JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (03) : 479 - 486
  • [35] Association between extent of resection on survival in adult brainstem high-grade glioma patients
    Joshua Doyle
    Adham M. Khalafallah
    Wuyang Yang
    Yi Sun
    Chetan Bettegowda
    Debraj Mukherjee
    Journal of Neuro-Oncology, 2019, 145 : 479 - 486
  • [36] Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma
    Tabouret, Emeline
    Boudouresque, Francoise
    Barrie, Maryline
    Matta, Mona
    Boucard, Celine
    Loundou, Anderson
    Carpentier, Antoine
    Sanson, Marc
    Metellus, Philippe
    Figarella-Branger, Dominique
    Ouafik, L'Houcine
    Chinot, Olivier
    NEURO-ONCOLOGY, 2014, 16 (03) : 392 - 399
  • [37] Residual low ADC and high FA at the resection margin correlate with poor chemoradiation response and overall survival in high-grade glioma patients
    Qu, Jinrong
    Qin, Lei
    Cheng, Suchun
    Leung, Katherine
    Li, Xiang
    Li, Hailiang
    Dai, Jianping
    Jiang, Tao
    Akgoz, Ayca
    Seethamraju, Ravi
    Wang, Qifeng
    Rahman, Rifaquat
    Li, Shaowu
    Ai, Lin
    Jiang, Tianzi
    Young, Geoffrey S.
    EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (03) : 657 - 664
  • [38] ASSOCIATION OF MATRIX METALLOPROTEINASE 2 (MMP2) BASELINE PLASMA LEVEL WITH RESPONSE AND SURVIVAL AND CHANGE OVERTIME IN PATIENTS TREATED WITH BEVACIZUMAB FOR RECURRENT HIGH GRADE GLIOMA
    Chinot, Olivier-L
    Boudouresque, Francoise
    Barrie, Maryline
    Matta, Mona
    Boucard, Celine
    Loundou, Anderson
    Figarella-Branger, Dominique
    Ouafik, L'Houcine
    Tabouret, Emeline
    NEURO-ONCOLOGY, 2014, 16
  • [39] Propylthiouracil-induced chemical[subclinical] hypothyroidism with high dose tamoxifen prolongs survival and increases tumor response rate in recurrent high-grade glioma
    Hercbergs, AA
    Suh, JH
    Lee, S
    Cohen, BH
    Stevens, GH
    Reddy, SK
    Peereboom, DM
    Elson, PJ
    Gupta, MK
    Barnett, GH
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 91 - 91
  • [40] Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients
    Bartl, Thomas
    Karacs, Jasmine
    Kreuzinger, Caroline
    Pfaffinger, Stephanie
    Kendler, Jonatan
    Ciocsirescu, Cristina
    Wolf, Andrea
    Reinthaller, Alexander
    Meyer, Elias
    Brandstetter, Maximilian
    Postl, Magdalena
    Langthaler, Eva
    Braicu, Elena
    Vergote, Ignace
    Cunnea, Paula
    Gourley, Charlie
    Schmitt, Wolfgang D.
    Cacsire Castillo-Tong, Dan
    Christoph, Grimm
    CANCERS, 2021, 13 (05) : 1 - 14